TANG OSCAR 4
4 · ACLARA BIOSCIENCES INC · Filed Dec 14, 2004
Insider Transaction Report
Form 4Exit
TANG OSCAR
Other
Transactions
- Disposition to Issuer
Common Stock
[F1]2004-12-10−162,500→ 0 total(indirect: In Managed Accounts) - Disposition to Issuer
Common Stock
[F2]2004-12-10−335,800→ 0 total(indirect: By Trust) - Disposition to Issuer
Common Stock
[F6][F3]2004-12-10−59,206→ 0 total(indirect: By Partnership) - Disposition to Issuer
Common Stock
[F4]2004-12-10−15,794→ 0 total(indirect: By Partnership) - Disposition to Issuer
Common Stock
[F5]2004-12-10−50,000→ 0 total
Footnotes (6)
- [F1]Disposed of pursuant to merger between Aclara Biosciences, Inc. and Virologic, Inc. in exchange for 276,250 shares of Virologic, Inc. common stock. Reporting Person also an equal number of contingent value rights, which may be settled in the form of additional shares of Virologic, Inc. common stock pursuant to the terms of the Agreement of Merger("Contingent Value Rights").
- [F2]Disposed of pursuant to merger between Aclara Biosciences, Inc. and Virologic, Inc., in exchange for 570,860 shares of Virologic, Inc. common stock. Reporting person also received 570,860 Contingent Value Rights.
- [F3]Disposed of pursuant to merger between Aclara Biosciences, Inc. and Virologic, Inc., in exchange for 100,650 shares of Virologic, Inc. common stock. Reporting person also received 100,650 Contingent Value Rights.
- [F4]Disposed of pursuant to merger between Aclara Biosciences, Inc. and Virologic, Inc., in exchange for 26,850 shares of Virologic, Inc. common stock. Reporting person also received 26,850 Contingent Value Rights.
- [F5]Disposed of pursuant to merger between Aclara Biosciences, Inc. and Virologic, Inc., in exchange for 85,000 shares of Virologic, Inc. common stock. Reporting person also received 85,000 Contingent Value Rights.
- [F6]Reporting person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of the securities for purposes of Section 16 or for any other purpose.
Signature
Oscar L. Tang|2004-12-14